Optimizing prehospital ST-segment elevation myocardial infarction pathways, medical dispatch types and acute

Emilie Lesaine1, Sahal Miganeh-Hadi1, Mathilde Borg2

  • 1CIC-EC 14-01, Inserm U1219, BPH, Institut Bergonié, CHU de Bordeaux, 33000 Bordeaux, France.

Insights

Efficient emergency medical services are vital for ST-segment elevation myocardial infarction (STEMI) patients. Mistriage and delays in emergency departments (EDs) significantly hinder optimal care pathways, impacting patient outcomes.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Health Services Research

Background:

  • Effective emergency medical services (EMS) management is critical for ST-segment elevation myocardial infarction (STEMI) patients.
  • Directing STEMI patients to the fastest pathway, bypassing emergency departments (EDs) when appropriate, improves outcomes.
  • Analysis of EMS pathways can identify improvements in patient care and outcomes.

Purpose of the Study:

  • To describe initial STEMI pathways focusing on dispatch management.
  • To analyze acute management times and revascularization strategies for different STEMI pathways.
  • To compare pathways: medical intensive care unit, PCI-capable hospital ED, and PCI-incapable hospital ED.

Main Methods:

  • Multicentre retrospective study of 8344 adult STEMI patients (2017-2021).
  • Inclusion criteria: STEMI diagnosis by emergency physicians within 24 hours of symptom onset.
  • Primary endpoint: proportion of patients missing the fastest pathway due to mistriage; Secondary endpoints: time intervals from symptom onset to balloon inflation.

Main Results:

  • 57% of patients followed the fastest pathway; 21% missed it due to mistriage.
  • Median ED time was 78 minutes (PCI-capable) vs. 109 minutes (PCI-incapable).
  • Only 11% received fibrinolysis in PCI-incapable EDs; 79% exceeded 120 minutes for primary PCI.

Conclusions:

  • Findings highlight the need for improved dispatch accuracy and dedicated STEMI networks in French EDs.
  • Time lost due to ED delays or mistriage represents significant missed opportunities for STEMI patients.
  • The role and effectiveness of fibrinolysis in STEMI management require re-evaluation.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...